AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ADHERIUM LIMITED Board/Management Information 2018

Jan 22, 2018

64305_rns_2018-01-22_3f5dfa19-a7e1-46ad-84a6-e66c29a9904c.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [211 x 51] intentionally omitted <==

Adherium CFO Resignation

San Mateo, CA - January 23, 2018: Adherium (ASX: ADR), a digital health company that improves medication adherence and patient outcomes, advises that it’s Chief Financial Officer has tendered his resignation.

Mr Marcotte will leave Adherium January 31, 2018 to take up a chief executive position in Silicon Valley.

Mr Arik Anderson, Adherium’s Group CEO said: “We wish Tim well in taking up his new CEO role, and Adherium will announce his replacement in due course.”

About Adherium

Adherium is a provider of digital health solutions. The Company develops, manufactures and supplies patients, pharmaceutical companies, healthcare providers and contract research organizations with the broadest range of "smart" medication sensors for respiratory medications to address sub-optimal medication use and improve health outcomes in chronic disease.

Adherium operates globally from bases in the USA, Europe and Australasia.

Inquiries

Global: Arik Anderson, [email protected] United States : Vik Panda, [email protected] Europe : Scott Fleming, [email protected], +31 6 4687 6989 Australia: Monsoon Communications, Rudi Michaelson, +61 3 9620 3333 Email: [email protected] Web: www.adherium.com